Our findings suggest potential therapeutic interventions for lowering IOP, particularly through the use of a ROCK/MYLK dual inhibitor in our TM-obstructed OHT model of NZW rabbit models and early-onset POAG. The gene discussed is MYLK; the disease is open-angle glaucoma.